Linden Thomas Advisory Services »

Kiniksa Pharmaceuticals shares owned by Linden Thomas Advisory Services

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Linden Thomas Advisory Services from 13F filings

Historical chart of Linden Thomas Advisory Services investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Linden Thomas Advisory Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 115k 17.54
2023-09-30 $2.0M 116k 17.37
2023-06-30 $816k 58k 14.08

More positions owned by Linden Thomas Advisory Services

Broadcom (AVGO)
salesforce (CRM)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Chemed Corp Com Stk (CHE)
Microsoft Corporation (MSFT)
Gartner (IT)
Intuit (INTU)
Lockheed Martin Corporation (LMT)
Netflix (NFLX)
FactSet Research Systems (FDS)
IDEXX Laboratories (IDXX)
Lam Research Corporation (LRCX)

View all positions for Linden Thomas Advisory Services

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals